Integrated Proteins re-designates Hiren Shah as CMD for five-year term
Integrated Proteins Ltd approved the re-designation of Hiren Dhirajlal Shah as Chairman and Managing Director for a five-year term starting July 24, 2026. The move requires shareholder approval at an EGM on August 20, 2026. Shah, previously Additional Executive Director, holds degrees in BCA and LL.B. and has extensive experience in finance and compliance. The appointment follows SEBI Listing Regulations and Companies Act provisions.

*this image is generated using AI for illustrative purposes only.
Integrated Proteins has moved to consolidate its leadership structure by approving the re-designation of Hiren Dhirajlal Shah as Chairman and Managing Director (CMD). The Board of Directors sanctioned the change during a meeting held on July 24, 2026, at the company’s registered office in Jamnagar, Gujarat. This strategic shift elevates Shah from his previous role as Additional Executive Director, signaling a focused approach to corporate governance and executive oversight for the listed protein products manufacturer.
The appointment is subject to ratification by shareholders at an Extra-Ordinary General Meeting (EGM). The Board has scheduled the EGM for August 20, 2026, to be conducted via Video Conferencing or Other Audio Visual Means (OAVM). Shareholders holding shares as of the cut-off date of August 13, 2026, will be eligible to vote. The e-voting window opens on August 17, 2026, at 9:00 AM and closes on August 19, 2026, at 5:00 PM. Mrs. Ankita Tejas Shah, a Practicing Company Secretary, has been appointed as the scrutinizer for the e-voting process.
Shah’s tenure as CMD will span five years, commencing on July 24, 2026, and concluding on July 23, 2031. The Board’s decision aligns with Sections 196, 197, and 203 of the Companies Act, 2013, read with Schedule V, and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014. The filing confirms that Shah is not debarred from holding directorial office by the Securities and Exchange Board of India (SEBI) or any other regulatory authority.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026. The company filed the details with BSE Limited, where it is listed under Scrip Code 519606.
Key Details of the Appointment
| Particulars | Details |
|---|---|
| Appointee | Hiren Dhirajlal Shah |
| New Designation | Chairman and Managing Director |
| Previous Role | Additional Executive Director |
| DIN | 09842161 |
| Tenure Start Date | July 24, 2026 |
| Tenure End Date | July 23, 2031 |
| Shareholder Approval | Required at EGM |
Leadership Profile
Hiren Dhirajlal Shah brings a multidisciplinary background to the top leadership role. He holds a Bachelor of Computer Applications (BCA) and a Bachelor of Laws (LL.B.) degree from Saurashtra University. His professional expertise spans finance, accounting, business administration, and corporate management. Over the years, Shah has been actively involved in financial planning, regulatory compliance, and strategic decision-making, providing Integrated Proteins with experienced oversight in both operational and legal domains. The Board noted no relationship disclosures between directors regarding this appointment.
Historical Stock Returns for Integrated Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.77% | -1.51% | -4.30% | +372.04% | +210.74% | +4,120.59% |
How might Hiren Dhirajlal Shah's combined legal and financial background influence Integrated Proteins' strategy for navigating upcoming regulatory changes in the protein manufacturing sector?
What specific operational or strategic initiatives is the board expected to prioritize under Shah's five-year tenure as CMD to drive revenue growth?
Could this leadership consolidation signal a shift in corporate governance that aims to improve investor confidence and stabilize stock performance on the BSE?


































